Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 01 Apr 2021 for Lineage Cell Therapeutics, Inc., €3,541.
Filing timeline
BuySaleAlexandra Hernandez
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Alexandra Hernandez: trading record in brief
All filings by Alexandra Hernandez on record concern Lineage Cell Therapeutics, Inc. The record holds 2 filings, all for trades on 30 March 2021.
Every open-market trade on record is a sale: 1 sale worth €11k. Other entries cover 1 option exercise.
Most recently, on 1 April 2021, the filings show an option exercise worth €3,541 in Lineage Cell Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alexandra Hernandez
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
- 6,000 shares@ US$0.691923.7% of flowCommon Shares, no par valueSEC:0001493152-21-007795:0
- 6,000 shares@ US$2.2376.3% of flowCommon Shares, no par valueSEC:0001493152-21-007795:1
2 of 2 declarations